NCT00626262View on ClinicalTrials.gov

Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

October 31, 2002

Study Completion Date

October 31, 2002

Conditions
Gastroesophageal Reflux Disease
Interventions
DRUG

Esomeprazole

Oral and Intravenous

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY